We are live on ! Find out more
GLS.WS

Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

Delisted

GLS.WS was delisted on the 3rd of January, 2023.

30 hedge funds and large institutions have $4.21M invested in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+30
Holders Change %
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
Reduced
Closed
Calls
$1.61M
Puts
Net Calls
+$1.61M
Net Calls Change
+$1.61M
Name Holding Trade Value Shares
Change
Change in
Stake
MSU
26
Mizuho Securities USA
New York
$6K +$5.84K +25,000 New
CL
27
CSS LLC
Illinois
$5K +$4.77K +20,400 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$4K +$3.82K +16,357 New
SM
29
Skaana Management
New York
$3K +$3.37K +14,403 New
WAM
30
Wolverine Asset Management
Illinois
$3K +$3.88K +16,581 New
TRCT
31
Tower Research Capital (TRC)
New York
+$25 +107 New

GLS.WS Hedge Fund Activity: Q1 2022 in Review

30 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) for Q1 2022, worth a combined $4.21M.

Buyers outnumbered sellers: 30 funds opened new GLS.WS positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Allianz Asset Management, opening a new position worth an estimated $879K.

  • 30 institutional investors held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $4.21M of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 stock for Q1 2022.
  • 30 funds opened new Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 positions in Q1 2022 and 0 closed out, a net change of +30 holders.
  • The largest Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 buyer in Q1 2022 was Allianz Asset Management, an estimated $879K added.

Based on aggregated 13F filings for Q1 2022.